Scleral Lens Market

Scleral Lens Market

Growth Factors of Scleral Lens Market

The scleral lens market size was valued at USD 301.4 million in 2023, and the market is now projected to grow from USD 327.0 million in 2024 to USD 770.6 million by 2032, exhibiting a CAGR of 11.3% during the forecast period of 2023-2030.

The COVID-19 pandemic negatively impacted the industry, resulting in supply chain issues and variations in demand leading to reduction in scleral lens market growth. Despite global efforts to manage disruption, the sector is gradually rebounding. Product demand is rebounding due to increased industrial activity and technological improvements, indicating a good market recovery. Investors in the refrigerants business encountered obstacles such as limited options, high material costs, and delayed project cycles. Moreover, lens manufacturing industries experienced decreased demand and slowed operations. To protect their employees against COVID-19, companies in the market needed to implement additional safety measures and maintain suitable behavior.

There is a growing global patient population with ocular illnesses that require efficient vision correction treatments. The prevalence of ocular conditions such uncorrected refractive errors, dry eye syndrome, and keratoconus is sharply rising. The demand for these goods is expected to be driven during the projected period by patients in developed and developing countries who are turning to more sophisticated treatments for the management of eye problems. The launch of novel products by major companies, the rise in corneal transplant procedures, and the growing use of scleral solutions for the treatment of ocular illnesses are other important factors driving the market's expansion. Furthermore, it is projected that the growing number of people wearing contact lenses would increase demand for these lenses.

The main medical disorders treated with scleral lenses are those associated with irregular corneas and illnesses of the ocular surface. To improve the quality of life for people with normal corneas, these lenses are now advised. The need for more recent SLs is rising since patients are no longer eligible for traditional lenses and can use them in lieu of surgery. The last several years have seen an expansion in the breadth of these lenses due to technological breakthroughs and increased manufacturing efficiencies. For example, these lenses were used off-label for the treatment of dry eye. But the labeling of these lenses now lists keratoconjunctivitis sicca as a therapeutic indication, according to the U.S. FDA.

Comprehensive Analysis of Scleral Lens Market

The scleral lens market is witnessing an exponential rate due to its market segmentation. This market expansion effectively provides a detailed geographical assessment considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by types and by end users. The types segmentation include, Mini-Scleral Lenses and Large-Scleral Lenses. However, the end users include Hospitals, Eye Clinics, clinics and others.

In scleral lens market, the North America region lead the medical devices market by benefitting a market size of USD 122.5 billion in 2023 owing to robust healthcare infrastructure and adoption of advanced medical technologies.

The prominent players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Bausch + Lomb (Canada), EssilorLuxottica (France), BostonSight (U.S.), Art Optical Contact Lens, Inc. (U.S.), Visionary Optics (Euclid Vision Group) (U.S.), TruForm Optics Inc. (U.S.), The Cooper Companies Inc. (U.S.), ABB Optical Group (U.S.), SynergEyes (U.S.), and AccuLens (U.S.) these market players provide a level-playing competitive landscape.

In August 2023, A scleral lens with improved lens design called Europa Tangent was released by Visionary Optics.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 11.3% from 2024 to 2032

Unit Value (USD Million) and Volume (1,000 units)

Segmentation By Type

• Mini-Scleral Lenses
• Large -Scleral Lenses

By End User

• Hospitals
• Eye Clinics
• Others

By Region

• North America (By Type and End-User)
• U.S.
• Canada
• Europe (By Type and End-User)
• U.K.
• Germany
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific (By Type and End-User)
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Rest of Asia Pacific
• Latin America (By Type and End-User)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa (By Type and End-User)
• Turkey
• Saudi Arabia
• UAE
• Rest of the Middle East & Africa